Arbutus Biopharma Corp (ABUS)
2.74
-0.01
(-0.36%)
USD |
NASDAQ |
Apr 24, 13:09
Arbutus Biopharma Max Drawdown (5Y): 96.69% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
March 31, 2024 | 96.69% |
February 29, 2024 | 96.69% |
January 31, 2024 | 96.69% |
December 31, 2023 | 96.69% |
November 30, 2023 | 96.69% |
October 31, 2023 | 96.69% |
September 30, 2023 | 96.69% |
August 31, 2023 | 96.69% |
July 31, 2023 | 96.69% |
June 30, 2023 | 96.69% |
May 31, 2023 | 96.69% |
April 30, 2023 | 96.69% |
March 31, 2023 | 96.69% |
February 28, 2023 | 96.69% |
January 31, 2023 | 96.69% |
December 31, 2022 | 96.69% |
November 30, 2022 | 96.69% |
October 31, 2022 | 96.69% |
September 30, 2022 | 96.69% |
August 31, 2022 | 96.69% |
July 31, 2022 | 96.69% |
June 30, 2022 | 96.69% |
May 31, 2022 | 96.69% |
April 30, 2022 | 96.69% |
March 31, 2022 | 96.69% |
Date | Value |
---|---|
February 28, 2022 | 96.69% |
January 31, 2022 | 96.69% |
December 31, 2021 | 96.69% |
November 30, 2021 | 96.69% |
October 31, 2021 | 96.69% |
September 30, 2021 | 96.69% |
August 31, 2021 | 96.69% |
July 31, 2021 | 96.69% |
June 30, 2021 | 96.69% |
May 31, 2021 | 96.69% |
April 30, 2021 | 96.69% |
March 31, 2021 | 96.69% |
February 28, 2021 | 96.69% |
January 31, 2021 | 96.69% |
December 31, 2020 | 96.69% |
November 30, 2020 | 96.69% |
October 31, 2020 | 96.69% |
September 30, 2020 | 96.69% |
August 31, 2020 | 96.69% |
July 31, 2020 | 96.69% |
June 30, 2020 | 96.69% |
May 31, 2020 | 96.69% |
April 30, 2020 | 96.69% |
March 31, 2020 | 96.69% |
February 29, 2020 | 96.69% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
92.08%
Minimum
Apr 2019
96.69%
Maximum
Oct 2019
96.46%
Average
96.69%
Median
Oct 2019
Max Drawdown (5Y) Benchmarks
Moderna Inc | 85.65% |
Pacira BioSciences Inc | 70.10% |
Chimerix Inc | 97.79% |
Karyopharm Therapeutics Inc | 97.56% |
Corvus Pharmaceuticals Inc | 95.28% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -34.90 |
Beta (5Y) | 2.034 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 97.26% |
Historical Sharpe Ratio (5Y) | -0.0857 |
Historical Sortino (5Y) | -0.1883 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 34.41% |